Conference Call Participants Jailendra Singh - Truist Securities Lisa Gill - J.P. Morgan Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity Inc. Taji Phillips - Jefferies Group Jamie Perse - Goldman Sachs Jeff Garro - Stephens Inc. Andrew Mok - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Whit Mayo - SVB Securities Ryan Langston - TD Cowen Sandy Draper - Guggenheim Partners Ryan Daniels - William Blair Thomas Kelliher - RBC Capital Markets Good day, and thank you for standing by. Welcom ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Company Participants Robert Borchert Shawn Morris We continue to see a very strong sales funnel with potential new providers across our markets and are maintaining a healthy business development pipeline as we look to enter additional states over the next few years. Separately, we are very excited and have launched and priced this morning a large secondary offering of the company's total diluted shares outstanding. This transaction substantially reduces or eliminates Goldman Sachs and Pamplona Capital's own ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Company Participants Taji Phillips - Jefferies David Larsen - BTIG Lisa Gill - JPMorgan Joshua Raskin - Nephron Research Jailendra Singh - Truist Securities Ryan Daniels - William Blair Sandy Draper - Guggenheim Jamie Perse - Goldman Sachs Richard Close - Canaccord Genuity Whit Mayo - SVB Jessica Tassan - Piper Sandler I would now like to hand the call back over to our speaker today, Robert Borchert, SVP of Investor and Corporate Communications. Today's press release highlighting our financial and operating ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-K _______________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, Inc. (Exact ...

(2) Platform Contribution is total revenue less the sum of physician and practice expense and cost of platform. (5) Amount represents stock-based compensation expense included in Cost of Platform. For the Nine Months Ended (3) Adjusted EBITDA is net income (loss) ottributable to Privid Heath Group, Inc. shoreholders and substition's excluding minority interests, provision (benefit) for income income, interest expense, depreciation and amortization, stock-based compensation, severance charges and other non-r ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Robert Borchert - Investor Relations Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer David Mountcastle - Chief Financial Officer Conference Call Participants Joshua Raskin - Nephron Research Jailendra Singh - Truist Richard Close - Canaccord Genuity Lisa Gill - JPMorgan Ryan Daniels - William Blair Sandy Draper - Guggenheim Whit Mayo - SVB D ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Robert Borchert - Senior Vice President, Investor and Corporate Communications Shawn Morris - Chief Executive Officer David Mountcastle - Executive Vice President and Chief Financial Officer Parth Mehrotra - President and Chief Operating Officer Conference Call Participants Joshua Raskin - Nephron Research LLC Albert Rice - Credit Suisse AG Lisa Gill - JPMorgan Chase & Co. Adam Ron - Bank ...

2 nd Quarter 2022 Results August 11, 2022 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer 1 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projections and forecasts. These forward ...